Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2*
- From the ‡Department of Pathology and the§Karmanos Cancer Institute and ¶Department of Chemistry, Wayne State University, Detroit, Michigan 48201
Abstract
The dissociation constants (K d) of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 for the active and latent forms of matrix metalloproteinase (MMP)-2 and MMP-9 were evaluated using surface plasmon resonance (SPR) and enzyme inhibition studies. SPR analysis shows biphasic kinetics with high (nm) and low (μm) affinity binding sites of TIMP-2 and TIMP-1 for MMP-2 (72- and 62-kDa species) and MMP-9 (92- and 82-kDa species), respectively. In contrast, binding data of TIMP-2 to an MMP-2 45-kDa active form lacking the C-terminal domain and to an MMP-2 C-terminal domain (CTD) fragment displays monophasic kinetics withK d values of 315 and 60 nm, respectively. This suggests that the CTD contains the high affinity binding site, whereas the catalytic domain contains the low affinity site. Also, binding of TIMP-2 to pro-MMP-2 is stronger at both the high and low affinity sites than the corresponding binding of TIMP-2 to the MMP-2 62-kDa form demonstrating the importance of the N-terminal prodomain. In addition, the K d value of TIMP-1 for the MMP-2 62-kDa species is 28.6 nm at the high affinity site, yet neither the MMP-2 45-kDa species nor the CTD interacts with TIMP-1. Enzyme inhibition studies demonstrate that TIMPs are slow binding inhibitors with monophasic inhibition kinetics. This suggests that a single binding event results in enzyme inhibition. The kinetic parameters for the onset of inhibition are fast (k on ∼105 m −1 s−1) with slow off rates (k off ∼10−3 s−1). The inhibition constants (K i) are in the 10−7–10−9 m range and correlate with the values determined by SPR.
Footnotes
-
↵* This work was supported by National Institutes of Health Grant CA-61986 (to R. F.), a Wayne State University postdoctoral fellowship (to M. W. O.), and U. S. Army Grant DAMD17-97-1-7174 (to S. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‖ To whom correspondence should be addressed: Dept. of Pathology, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201. Tel.: 313-577-1218; Fax: 313-577-8180; E-mail:rfridman{at}med.wayne.edu.
-
↵1 The abbreviations used are: MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; PAGE, polyacrylamide gel electrophoresis; Me2SO, dimethyl sulfoxide; CTD, C-terminal domain; SPR, surface plasmon resonance; MT1-MMP, membrane type 1-MMP.
-
↵2 Yu, A. E., Fisher, R. J., Kleiner, D. E., and Stetler-Stevenson, W. G. (1996) Abstract from the Inhibitors of Metalloproteinases in Development and Disease TIMPs, September 25–29, 1996, Banff, Alberta, Canada.
-
- Received June 6, 1997.
- Revision received September 2, 1997.










